EUVIMEDEUVIMED entdecken
Crossref

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose

Samantha Anderer

JAMA · 28.07.2026 · 336 (4) · 278

DOI: 10.1001/jama.2026.9470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 28.07.2026. Verfasst von Samantha Anderer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Anderer, S. (2026). FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose. JAMA, 336(4), 278. https://doi.org/10.1001/jama.2026.9470

Vancouver

Anderer S. FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose. JAMA. 2026;336(4):278. doi:10.1001/jama.2026.9470

BibTeX
@article{Anderer2026,
  author = {Anderer, Samantha},
  title = {FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {4},
  pages = {278},
  doi = {10.1001/jama.2026.9470}
}
Kostenlos starten →